SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (8344)1/17/1999 10:06:00 PM
From: Bluegreen  Respond to of 17367
 
Texas, you say tomato I say.... I say it is further evidence against the FDA and kudos to LGND. As far as Neuprex is concerned, my kid gets it based on efficacy of tiny phase II, how about your kid? Remember that Neuprex up to this point is very safe. Once more why blame Xoma in regard to E5 when that was PFE's baby and they called all the shots, not Xoma.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News